Medical Cannabis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Medical Cannabis stocks.

Medical Cannabis Stocks Recent News

Date Stock Title
Jul 3 CGC Decibel's Dominance In Pre-Rolls Tested By Market Shifts And 16% Revenue Drop: What Investors Need To Know
Jul 3 OGI Decibel's Dominance In Pre-Rolls Tested By Market Shifts And 16% Revenue Drop: What Investors Need To Know
Jul 3 TLRY Decibel's Dominance In Pre-Rolls Tested By Market Shifts And 16% Revenue Drop: What Investors Need To Know
Jul 2 TLRY Marijuana Stocks To Buy And Watch
Jul 1 CGC Roundhill Cannabis ETF (WEED) Waives Fees to 0.00%
Jul 1 TLRY Tilray Brands, Inc. (TLRY): Is It the Best Pot Stock to Buy Now?
Jun 30 VFF The Biggest Vertical Farming Company
Jun 29 TLRY Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
Jun 29 OGI Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
Jun 29 CGC Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
Jun 29 ACB Will Biden's Shaky Debate Performance Affect Cannabis Reform? How A Trump Return Could Reshape Marijuana Policy
Jun 28 TLRY Cannabis producer Tilray debuts nonalcoholic beer Runner’s High
Jun 28 HITI High Tide Opens Two New Canna Cabana Stores in Alberta and Saskatchewan
Jun 27 VFF Pure Sunfarms Launches Grower-Led ‘Trials’ Program
Jun 27 TLRY Tilray Brands Brews Up Summer Fun for the Fourth of July
Jun 27 TLRY Tilray Brands Announces Runner's High Brewing Company – Its New Brand of Premium Non-Alcoholic Brews
Jun 27 MJ Amplify ETFs Declares June Income Distributions for its ETFs
Medical Cannabis

Medical cannabis, or medical marijuana, is cannabis and cannabinoids that are recommended by doctors for their patients. The use of cannabis as medicine has not been rigorously tested due to production restrictions and other governmental regulations. Limited evidence suggests that cannabis can reduce nausea and vomiting during chemotherapy, improve appetite in people with HIV/AIDS, and reduce chronic pain and muscle spasms.Short-term use increases the risk of minor and major adverse effects. Common side effects include dizziness, feeling tired, vomiting, and hallucinations. Long-term effects of cannabis are not clear. Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.The Cannabis plant has a history of medicinal use dating back thousands of years in many cultures. A number of medical organizations have requested removal of cannabis from the list of Schedule I controlled substances, followed by regulatory and scientific review. Others oppose its legalization, such as the American Academy of Pediatrics.Medical cannabis can be administered through a variety of methods, including capsules, lozenges, tinctures, dermal patches, oral or dermal sprays, cannabis edibles, and vaporizing or smoking dried buds. Synthetic cannabinoids are available for prescription use in some countries, such as dronabinol and nabilone. Countries that allow the medical use of whole-plant cannabis include Australia, Canada, Chile, Colombia, Germany, Greece, Israel, Italy, the Netherlands, Peru, Poland, Portugal, and Uruguay. In the United States, 33 states and the District of Columbia have legalized cannabis for medical purposes, beginning with the passage of California's Proposition 215 in 1996. Although cannabis remains prohibited for any use at the federal level, the Rohrabacher–Farr amendment was enacted in December 2014, limiting the ability of federal law to be enforced in states where medical cannabis has been legalized.

Browse All Tags